Quick Answer
DEXCOM INC reported Total Revenue of $4.66 billion for fiscal year 2025.
DEXCOM INC Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $4.66B | +15.6% |
| 2024 | $4.03B | +11.3% |
| 2023 | $3.62B | +24.5% |
| 2022 | $2.91B | +18.8% |
| 2021 | $2.45B | +27.1% |
| 2020 | $1.93B | +30.5% |
| 2019 | $1.48B | +43.1% |
| 2018 | $1.03B | +43.6% |
| 2017 | $718.50M | +25.3% |
| 2016 | $573.30M | +42.6% |
| 2015 | $402.00M | +55.1% |
| 2014 | $259.20M | +62.0% |
| 2013 | $160.00M | +60.2% |
| 2012 | $99.90M | +30.9% |
| 2011 | $76.30M | +57.0% |
| 2010 | $48.60M | +63.7% |
| 2009 | $29.69M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.21B | +21.6% | +4.5% |
| June 30, 2025 | $1.16B | +15.2% | +11.7% |
| March 31, 2025 | $1.04B | +12.5% | +4.2% |
| September 30, 2024 | $994.20M | +2.0% | -1.0% |
| June 30, 2024 | $1.00B | +15.3% | +9.0% |
| March 31, 2024 | $921.00M | +24.2% | -5.5% |
| September 30, 2023 | $975.00M | +26.7% | +11.9% |
| June 30, 2023 | $871.30M | +25.2% | +17.5% |
- DEXCOM INC showed an increase of +15.6% in Total Revenue compared to the prior fiscal year.
- Over the 2009–2025 period, DEXCOM INC’s total revenue has grown by 15600.7% (from $29.69 million to $4.66 billion).
- The most recent figure is from DEXCOM INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: